BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 38113855)

  • 1. Scalable production of homogeneous cardiac organoids derived from human pluripotent stem cells.
    Moriwaki T; Tani H; Haga K; Morita-Umei Y; Soma Y; Umei TC; Sekine O; Takatsuna K; Kishino Y; Kanazawa H; Fujita J; Fukuda K; Tohyama S; Ieda M
    Cell Rep Methods; 2023 Dec; 3(12):100666. PubMed ID: 38113855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human-induced pluripotent stem cell-derived cardiomyocytes, 3D cardiac structures, and heart-on-a-chip as tools for drug research.
    Andrysiak K; Stępniewski J; Dulak J
    Pflugers Arch; 2021 Jul; 473(7):1061-1085. PubMed ID: 33629131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation, High-Throughput Screening, and Biobanking of Human-Induced Pluripotent Stem Cell-Derived Cardiac Spheroids.
    Maas RGC; Beekink T; Chirico N; Snijders Blok CJB; Dokter I; Sampaio-Pinto V; van Mil A; Doevendans PA; Buikema JW; Sluijter JPG; Stillitano F
    J Vis Exp; 2023 Mar; (193):. PubMed ID: 36971448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemically Defined Production of Tri-Lineage Human iPSC-Derived Cardiac Spheroids.
    Arzt M; Pohlman S; Mozneb M; Sharma A
    Curr Protoc; 2023 May; 3(5):e767. PubMed ID: 37154466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in pluripotent stem cell-derived cardiac organoids and heart-on-chip applications for studying anti-cancer drug-induced cardiotoxicity.
    Liu S; Fang C; Zhong C; Li J; Xiao Q
    Cell Biol Toxicol; 2023 Dec; 39(6):2527-2549. PubMed ID: 37889357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a transplant injection device for optimal distribution and retention of human induced pluripotent stem cell‒derived cardiomyocytes.
    Tabei R; Kawaguchi S; Kanazawa H; Tohyama S; Hirano A; Handa N; Hishikawa S; Teratani T; Kunita S; Fukuda J; Mugishima Y; Suzuki T; Nakajima K; Seki T; Kishino Y; Okada M; Yamazaki M; Okamoto K; Shimizu H; Kobayashi E; Tabata Y; Fujita J; Fukuda K
    J Heart Lung Transplant; 2019 Feb; 38(2):203-214. PubMed ID: 30691596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells.
    Ho BX; Pek NMQ; Soh BS
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling Cardiovascular Diseases with hiPSC-Derived Cardiomyocytes in 2D and 3D Cultures.
    Sacchetto C; Vitiello L; de Windt LJ; Rampazzo A; Calore M
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32403456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
    Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
    Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of 3D cardiac tissue with synchronous powerful beating using human cardiomyocytes from human iPS cells prepared by a convenient differentiation method.
    Sasano Y; Fukumoto K; Tsukamoto Y; Akagi T; Akashi M
    J Biosci Bioeng; 2020 Jun; 129(6):749-755. PubMed ID: 32151485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From Spheroids to Organoids: The Next Generation of Model Systems of Human Cardiac Regeneration in a Dish.
    Scalise M; Marino F; Salerno L; Cianflone E; Molinaro C; Salerno N; De Angelis A; Viglietto G; Urbanek K; Torella D
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Characterization of Isogenic Cardiac Organoids from Human-Induced Pluripotent Stem Cells Under Supplement Starvation Regimen.
    Patino-Guerrero A; Ponce Wong RD; Kodibagkar VD; Zhu W; Migrino RQ; Graudejus O; Nikkhah M
    ACS Biomater Sci Eng; 2023 Feb; 9(2):944-958. PubMed ID: 36583992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of functional cardiomyocytes and cardiac tissue from human induced pluripotent stem cells for regenerative therapy.
    Tani H; Tohyama S; Kishino Y; Kanazawa H; Fukuda K
    J Mol Cell Cardiol; 2022 Mar; 164():83-91. PubMed ID: 34822838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of intestinal organoids derived from human pluripotent stem cells for drug testing.
    Yoshida S; Miwa H; Kawachi T; Kume S; Takahashi K
    Sci Rep; 2020 Apr; 10(1):5989. PubMed ID: 32249832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human iPSC-derived hepatocytes in 2D and 3D suspension culture for cryopreservation and in vitro toxicity studies.
    Altmaier S; Meiser I; Lemesre E; Chanrion B; Steeg R; Leonte LE; Holst B; Nielsen BS; Clausen C; Schmidt K; Vinggaard AM; Zimmermann H; Neubauer JC; Rasmussen MA
    Reprod Toxicol; 2022 Aug; 111():68-80. PubMed ID: 35598806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting hiPSC-CM pacemaker function in a cardiac organoid model.
    Schulze ML; Lemoine MD; Fischer AW; Scherschel K; David R; Riecken K; Hansen A; Eschenhagen T; Ulmer BM
    Biomaterials; 2019 Jun; 206():133-145. PubMed ID: 30933775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Situ Expansion, Differentiation, and Electromechanical Coupling of Human Cardiac Muscle in a 3D Bioprinted, Chambered Organoid.
    Kupfer ME; Lin WH; Ravikumar V; Qiu K; Wang L; Gao L; Bhuiyan DB; Lenz M; Ai J; Mahutga RR; Townsend D; Zhang J; McAlpine MC; Tolkacheva EG; Ogle BM
    Circ Res; 2020 Jul; 127(2):207-224. PubMed ID: 32228120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in regulating the proliferation or maturation of human-induced pluripotent stem cell-derived cardiomyocytes.
    Yang H; Yang Y; Kiskin FN; Shen M; Zhang JZ
    Stem Cell Res Ther; 2023 Aug; 14(1):228. PubMed ID: 37649113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scalable Generation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Hamad S; Derichsweiler D; Hescheler J; Pfannkuche K
    Methods Mol Biol; 2022; 2454():145-161. PubMed ID: 34664217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of spatial-patterned early-developing cardiac organoids using human pluripotent stem cells.
    Hoang P; Wang J; Conklin BR; Healy KE; Ma Z
    Nat Protoc; 2018 Apr; 13(4):723-737. PubMed ID: 29543795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.